Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 216 Pages
Report ld: 6333777
Request Sample
Customized Report
Lateral Flow Immunochromatographic Assay Testing Market Size(US$)

CAGR 2026-2032
6.8%
Market Size,2032
USD 6,920
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lateral Flow Immunochromatographic Assay Testing market is projected to grow from US$ 4394 million in 2025 to US$ 6920 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A lateral flow test is simple: the sample flows along the device, meeting conjugated labels and antibodies that bind to the target analyte if it's present. These binding reagents will continue along the device to the test lines, which bind to the test line to show a positive result.
From a downstream perspective, Cardiovascular Testing accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Lateral Flow Immunochromatographic Assay Testing leading manufacturers (including Abbott, Roche, QuidelOrtho, Wondfo Biotech, Getein Biotech, SD Biosensor, Orient Gene, ReLIA Biotech, ACON Biotech, Intec PRODUCT, etc.), dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Lateral Flow Immunochromatographic Assay Testing market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Lateral Flow Immunochromatographic Assay Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Lateral Flow Immunochromatographic Assay Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Lateral Flow Immunochromatographic Assay Testing Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Immunocolloidal Gold Technology
1.2.3 Immunofluorescence Technology
1.3 Market Segmentation by Application
1.3.1 Global Lateral Flow Immunochromatographic Assay Testing Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Cardiovascular Testing
1.3.3 Infectious Disease Testing
1.3.4 Drug Abuse Testing
1.3.5 Pregnancy Testing
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lateral Flow Immunochromatographic Assay Testing Revenue Estimates and Forecasts (2021-2032)
2.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Lateral Flow Immunochromatographic Assay Testing Sales Estimates and Forecasts (2021-2032)
2.4 Global Lateral Flow Immunochromatographic Assay Testing Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Lateral Flow Immunochromatographic Assay Testing Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Lateral Flow Immunochromatographic Assay Testing Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Immunocolloidal Gold Technology: Market Share by Key Manufacturers
3.5.2 Immunofluorescence Technology: Market Share by Key Manufacturers
3.6 Global Lateral Flow Immunochromatographic Assay Testing Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Lateral Flow Immunochromatographic Assay Testing Sales Performance by Type
4.1.1 Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Type (2021-2032)
4.1.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Lateral Flow Immunochromatographic Assay Testing Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Lateral Flow Immunochromatographic Assay Testing Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Lateral Flow Immunochromatographic Assay Testing Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Lateral Flow Immunochromatographic Assay Testing Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.1.4 Abbott Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Abbott Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.1.6 Abbott Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.1.7 Abbott Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.1.8 Abbott Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Business Overview
11.2.3 Roche Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.2.4 Roche Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Roche Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.2.6 Roche Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.2.7 Roche Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.2.8 Roche Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.2.9 Roche Recent Developments
11.3 QuidelOrtho
11.3.1 QuidelOrtho Corporation Information
11.3.2 QuidelOrtho Business Overview
11.3.3 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.3.4 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.3.6 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.3.7 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.3.8 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.3.9 QuidelOrtho Recent Developments
11.4 Wondfo Biotech
11.4.1 Wondfo Biotech Corporation Information
11.4.2 Wondfo Biotech Business Overview
11.4.3 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.4.4 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.4.6 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.4.7 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.4.8 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.4.9 Wondfo Biotech Recent Developments
11.5 Getein Biotech
11.5.1 Getein Biotech Corporation Information
11.5.2 Getein Biotech Business Overview
11.5.3 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.5.4 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.5.6 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.5.7 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.5.8 Getein Biotech Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.5.9 Getein Biotech Recent Developments
11.6 SD Biosensor
11.6.1 SD Biosensor Corporation Information
11.6.2 SD Biosensor Business Overview
11.6.3 SD Biosensor Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.6.4 SD Biosensor Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 SD Biosensor Recent Developments
11.7 Orient Gene
11.7.1 Orient Gene Corporation Information
11.7.2 Orient Gene Business Overview
11.7.3 Orient Gene Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.7.4 Orient Gene Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Orient Gene Recent Developments
11.8 ReLIA Biotech
11.8.1 ReLIA Biotech Corporation Information
11.8.2 ReLIA Biotech Business Overview
11.8.3 ReLIA Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.8.4 ReLIA Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 ReLIA Biotech Recent Developments
11.9 ACON Biotech
11.9.1 ACON Biotech Corporation Information
11.9.2 ACON Biotech Business Overview
11.9.3 ACON Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.9.4 ACON Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 ACON Biotech Recent Developments
11.10 Intec PRODUCT
11.10.1 Intec PRODUCT Corporation Information
11.10.2 Intec PRODUCT Business Overview
11.10.3 Intec PRODUCT Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.10.4 Intec PRODUCT Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Intec PRODUCT Recent Developments
11.11 Equinox Biotech Co
11.11.1 Equinox Biotech Co Corporation Information
11.11.2 Equinox Biotech Co Business Overview
11.11.3 Equinox Biotech Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.11.4 Equinox Biotech Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Equinox Biotech Co Recent Developments
11.12 Shanghai Kehua Bio-engineering Co
11.12.1 Shanghai Kehua Bio-engineering Co Corporation Information
11.12.2 Shanghai Kehua Bio-engineering Co Business Overview
11.12.3 Shanghai Kehua Bio-engineering Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.12.4 Shanghai Kehua Bio-engineering Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Shanghai Kehua Bio-engineering Co Recent Developments
11.13 Biotest Biotech
11.13.1 Biotest Biotech Corporation Information
11.13.2 Biotest Biotech Business Overview
11.13.3 Biotest Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.13.4 Biotest Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Biotest Biotech Recent Developments
11.14 Assure Tech
11.14.1 Assure Tech Corporation Information
11.14.2 Assure Tech Business Overview
11.14.3 Assure Tech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.14.4 Assure Tech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Assure Tech Recent Developments
11.15 Core Technology Co
11.15.1 Core Technology Co Corporation Information
11.15.2 Core Technology Co Business Overview
11.15.3 Core Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.15.4 Core Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Core Technology Co Recent Developments
11.16 Chongqing Zhongyuan BIO-TECHNOLOGY Co
11.16.1 Chongqing Zhongyuan BIO-TECHNOLOGY Co Corporation Information
11.16.2 Chongqing Zhongyuan BIO-TECHNOLOGY Co Business Overview
11.16.3 Chongqing Zhongyuan BIO-TECHNOLOGY Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.16.4 Chongqing Zhongyuan BIO-TECHNOLOGY Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Chongqing Zhongyuan BIO-TECHNOLOGY Co Recent Developments
11.17 Life Origin Biotech
11.17.1 Life Origin Biotech Corporation Information
11.17.2 Life Origin Biotech Business Overview
11.17.3 Life Origin Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.17.4 Life Origin Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Life Origin Biotech Recent Developments
11.18 Biotime
11.18.1 Biotime Corporation Information
11.18.2 Biotime Business Overview
11.18.3 Biotime Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.18.4 Biotime Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Biotime Recent Developments
11.19 Anhui DEEPBLUE Medical Technology Co
11.19.1 Anhui DEEPBLUE Medical Technology Co Corporation Information
11.19.2 Anhui DEEPBLUE Medical Technology Co Business Overview
11.19.3 Anhui DEEPBLUE Medical Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.19.4 Anhui DEEPBLUE Medical Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Anhui DEEPBLUE Medical Technology Co Recent Developments
11.20 Wantai BioPharm
11.20.1 Wantai BioPharm Corporation Information
11.20.2 Wantai BioPharm Business Overview
11.20.3 Wantai BioPharm Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.20.4 Wantai BioPharm Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Wantai BioPharm Recent Developments
11.21 Joinstar Biomedical Technology Co
11.21.1 Joinstar Biomedical Technology Co Corporation Information
11.21.2 Joinstar Biomedical Technology Co Business Overview
11.21.3 Joinstar Biomedical Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.21.4 Joinstar Biomedical Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Joinstar Biomedical Technology Co Recent Developments
11.22 J.H.Bio-Tec
11.22.1 J.H.Bio-Tec Corporation Information
11.22.2 J.H.Bio-Tec Business Overview
11.22.3 J.H.Bio-Tec Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.22.4 J.H.Bio-Tec Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 J.H.Bio-Tec Recent Developments
11.23 Hangzhou Clongene Biotech Co
11.23.1 Hangzhou Clongene Biotech Co Corporation Information
11.23.2 Hangzhou Clongene Biotech Co Business Overview
11.23.3 Hangzhou Clongene Biotech Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.23.4 Hangzhou Clongene Biotech Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Hangzhou Clongene Biotech Co Recent Developments
11.24 BIOHIT Healthcare
11.24.1 BIOHIT Healthcare
11.24.2 BIOHIT Healthcare
11.24.3 BIOHIT Healthcare
11.24.4 BIOHIT Healthcare
11.24.5 BIOHIT Healthcare
11.25 Nanjing Vazyme Biotech Co
11.25.1 Nanjing Vazyme Biotech Co Corporation Information
11.25.2 Nanjing Vazyme Biotech Co Business Overview
11.25.3 Nanjing Vazyme Biotech Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.25.4 Nanjing Vazyme Biotech Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Nanjing Vazyme Biotech Co Recent Developments
11.26 Shenzhen GLD Biotechnology Co
11.26.1 Shenzhen GLD Biotechnology Co Corporation Information
11.26.2 Shenzhen GLD Biotechnology Co Business Overview
11.26.3 Shenzhen GLD Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.26.4 Shenzhen GLD Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Shenzhen GLD Biotechnology Co Recent Developments
11.27 Hunan beixier Biotechnology Co
11.27.1 Hunan beixier Biotechnology Co Corporation Information
11.27.2 Hunan beixier Biotechnology Co Business Overview
11.27.3 Hunan beixier Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.27.4 Hunan beixier Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Hunan beixier Biotechnology Co Recent Developments
11.28 Shandong Kanghua Biotechnology Co
11.28.1 Shandong Kanghua Biotechnology Co Corporation Information
11.28.2 Shandong Kanghua Biotechnology Co Business Overview
11.28.3 Shandong Kanghua Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.28.4 Shandong Kanghua Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 Shandong Kanghua Biotechnology Co Recent Developments
11.29 BOSON BIOTECH
11.29.1 BOSON BIOTECH Corporation Information
11.29.2 BOSON BIOTECH Business Overview
11.29.3 BOSON BIOTECH Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.29.4 BOSON BIOTECH Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 BOSON BIOTECH Recent Developments
11.30 AVE Science & Technology Co
11.30.1 AVE Science & Technology Co Corporation Information
11.30.2 AVE Science & Technology Co Business Overview
11.30.3 AVE Science & Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.30.4 AVE Science & Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.30.5 AVE Science & Technology Co Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Lateral Flow Immunochromatographic Assay Testing Industry Chain
12.2 Lateral Flow Immunochromatographic Assay Testing Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Lateral Flow Immunochromatographic Assay Testing Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Lateral Flow Immunochromatographic Assay Testing Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Lateral Flow Immunochromatographic Assay Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Lateral Flow Immunochromatographic Assay Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Lateral Flow Immunochromatographic Assay Testing market size was US$ 4394 million in 2025 and is forecast to reach a readjusted size of US$ 6920 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 126
USD 4250.00
(Single User License)
The global market for Lateral Flow Immunochromatographic Assay Testing was estimated to be worth US$ 4394 million in 2025 and is projected to reach US$ 6920 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 183
USD 3950.00
(Single User License)
The global Lateral Flow Immunochromatographic Assay Testing market was valued at US$ 4394 million in 2025 and is anticipated to reach US$ 6920 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 153
USD 2900.00
(Single User License)
The global Lateral Flow Immunochromatographic Assay Testing market is projected to grow from US$ 4141 million in 2024 to US$ 6521 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 218
USD 4900.00
(Single User License)
The global Lateral Flow Immunochromatographic Assay Testing market size was US$ 4141 million in 2024 and is forecast to a readjusted size of US$ 6521 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 121
USD 4250.00
(Single User License)
The global market for Lateral Flow Immunochromatographic Assay Testing was estimated to be worth US$ 4141 million in 2024 and is forecast to a readjusted size of US$ 6521 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 185
USD 3950.00
(Single User License)
The global market for Lateral Flow Immunochromatographic Assay Testing was valued at US$ 4141 million in the year 2024 and is projected to reach a revised size of US$ 6521 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-03-10
Pages: 127
USD 2900.00
(Single User License)
A lateral flow test is simple: the sample flows along the device, meeting conjugated labels and antibodies that bind to the target analyte if it's present. These binding reagents will continue along the device to the test lines, which bind to the test line to show a positive result.
Published Date: 2024-09-04
Pages: 119
USD 2900.00
(Single User License)
A lateral flow test is simple: the sample flows along the device, meeting conjugated labels and antibodies that bind to the target analyte if it's present. These binding reagents will continue along the device to the test lines, which bind to the test line to show a positive result.
Published Date: 2024-09-04
Pages: 190
USD 4350.00
(Single User License)
A lateral flow test is simple: the sample flows along the device, meeting conjugated labels and antibodies that bind to the target analyte if it's present. These binding reagents will continue along the device to the test lines, which bind to the test line to show a positive result.
Published Date: 2024-09-04
Pages: 217
USD 4900.00
(Single User License)
The global Lateral Flow Immunochromatographic Assay Testing market size was US$ 4394 million in 2025 and is forecast to reach a readjusted size of US$ 6920 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 126
The global market for Lateral Flow Immunochromatographic Assay Testing was estimated to be worth US$ 4394 million in 2025 and is projected to reach US$ 6920 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 183
The global Lateral Flow Immunochromatographic Assay Testing market was valued at US$ 4394 million in 2025 and is anticipated to reach US$ 6920 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 153
The global Lateral Flow Immunochromatographic Assay Testing market is projected to grow from US$ 4141 million in 2024 to US$ 6521 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 218
The global Lateral Flow Immunochromatographic Assay Testing market size was US$ 4141 million in 2024 and is forecast to a readjusted size of US$ 6521 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 121
The global market for Lateral Flow Immunochromatographic Assay Testing was estimated to be worth US$ 4141 million in 2024 and is forecast to a readjusted size of US$ 6521 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 185
The global market for Lateral Flow Immunochromatographic Assay Testing was valued at US$ 4141 million in the year 2024 and is projected to reach a revised size of US$ 6521 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-03-10
Pages: 127
A lateral flow test is simple: the sample flows along the device, meeting conjugated labels and antibodies that bind to the target analyte if it's present. These binding reagents will continue along the device to the test lines, which bind to the test line to show a positive result.
Published: 2024-09-04
Pages: 119
A lateral flow test is simple: the sample flows along the device, meeting conjugated labels and antibodies that bind to the target analyte if it's present. These binding reagents will continue along the device to the test lines, which bind to the test line to show a positive result.
Published: 2024-09-04
Pages: 190
A lateral flow test is simple: the sample flows along the device, meeting conjugated labels and antibodies that bind to the target analyte if it's present. These binding reagents will continue along the device to the test lines, which bind to the test line to show a positive result.
Published: 2024-09-04
Pages: 217
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now